WHO backs use of GLP-1 drugs for weight loss, along with diet, exercise
WHO guidelines say GLP-1 drugs are effective as long-term treatment for obesity in adults, barring pregnant women, alongside diet, exercise interventions; call for equitable access to reduce global obesity costs…
FDA Approves First Generic Daily GLP-1 Injection for Type 2 Diabetes
The FDA today approved the first generic referencing the glucagon-like peptide-1 (GLP-1) receptor agonist liraglutide (Victoza), an 18 mg/3 mL injection, to improve glycemic control in patients aged 10 years and older…
